Skip to main content

Table 1 Expression of claudin-6, occludin and MMP-2and clinicopathological characteristics in breast carcinoma patients

From: Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma

Variables No. Claudin-6   Occludin   MMP-2  
Positive Negative p Positive Negative p Positive Negative p
Patient Age           
 20-40 9 6 3 0.696* 4 5 0.846* 6 3 0.900*
 41-60 20 14 6   11 9   15 5  
 61-80 7 5 2   4 3   5 2  
Histology           
 Ovarian papillary serous carcinoma 36 25 11 0.007 19 17 0.108* 26 10 0.001
 Ovarian serous adenomas 26 9 17   19 7   8 18  
Pathological Grade          
 I 14 9 5 0.696* 8 6 0.918* 9 5 0.6820*
 II 12 8 4   6 6   9 3  
 III 10 8 2   5 5   8 2  
Clinical Stage          
 I-II 20 13 7 0.777* 10 10 0.709* 11 9 0.028
 III-IV 16 12 4   9 7   15 1  
Metastasis           
 Positive 13 11 2 0.267* 7 6 0.923* 12 1 0.037
 Negative 23 14 9   12 11   14 9  
  1. chi-square test.
  2. *No statistical significance.